ATE468123T1 - Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität - Google Patents

Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität

Info

Publication number
ATE468123T1
ATE468123T1 AT03760696T AT03760696T ATE468123T1 AT E468123 T1 ATE468123 T1 AT E468123T1 AT 03760696 T AT03760696 T AT 03760696T AT 03760696 T AT03760696 T AT 03760696T AT E468123 T1 ATE468123 T1 AT E468123T1
Authority
AT
Austria
Prior art keywords
aggressiveness
anxiety
pheromones
calming
bird
Prior art date
Application number
AT03760696T
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of ATE468123T1 publication Critical patent/ATE468123T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03760696T 2002-06-19 2003-06-19 Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität ATE468123T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
ATE468123T1 true ATE468123T1 (de) 2010-06-15

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03760696T ATE468123T1 (de) 2002-06-19 2003-06-19 Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität

Country Status (12)

Country Link
EP (1) EP1531839B1 (de)
JP (1) JP4863619B2 (de)
CN (1) CN100508968C (de)
AT (1) ATE468123T1 (de)
AU (1) AU2003246372B8 (de)
BR (1) BRPI0311934B1 (de)
CA (1) CA2490681C (de)
DK (1) DK1531839T3 (de)
ES (1) ES2345099T3 (de)
MX (1) MXPA04013005A (de)
PT (1) PT1531839E (de)
WO (1) WO2004000336A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629286B2 (ja) 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
AU2016221929A1 (en) * 2015-02-20 2017-07-13 Société des Produits Nestlé S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) * 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
WO2019122424A1 (fr) 2017-12-22 2019-06-27 Ceva Sante Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
NO308197B1 (no) * 1998-01-21 2000-08-14 Fideline Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
ES2237189T3 (es) * 1998-11-02 2005-07-16 Gilead Sciences, Inc. Terapia de combinacion para tratar virus de la hepatitis b.

Also Published As

Publication number Publication date
MXPA04013005A (es) 2005-09-12
DK1531839T3 (da) 2010-09-13
JP2006508038A (ja) 2006-03-09
EP1531839A1 (de) 2005-05-25
CA2490681C (en) 2012-01-24
CN100508968C (zh) 2009-07-08
CA2490681A1 (en) 2003-12-31
EP1531839B1 (de) 2010-05-19
ES2345099T3 (es) 2010-09-15
AU2003246372B2 (en) 2008-11-27
BR0311934A (pt) 2005-04-05
WO2004000336A1 (en) 2003-12-31
PT1531839E (pt) 2010-07-21
CN1668318A (zh) 2005-09-14
AU2003246372B8 (en) 2009-03-26
BRPI0311934B1 (pt) 2015-05-26
AU2003246372A1 (en) 2004-01-06
JP4863619B2 (ja) 2012-01-25

Similar Documents

Publication Publication Date Title
ATE239464T1 (de) Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen
BRPI0515316A (pt) compostos de imidazoquinolina
ATE397936T1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
AR047529A1 (es) Compuestos de quinolina sustituidos
ES2045017T3 (es) Derivado de benzotiazol, su utilizacion y compuestos farmaceuticos que lo comprenden.
BRPI0401904A (pt) Composição de gordura ou óleo
ES2139853T3 (es) Propiedades de las feromonas faciales de los gatos.
DE60312011D1 (de) Schutz von riechstoffen in einer wachskerze unter verwendung eines antioxidans
ITMI20022627A1 (it) Uso di una miscela di esteri di acidi grassi come combustibile
EA200700382A1 (ru) Фунгицидные композиции
BRPI0413490A (pt) novos compostos
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
TR200001688T2 (tr) TTS içeren bir antioksidant.
ATE468123T1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
CL2019003072A1 (es) Composiciones nutricionales y farmacéuticas encapsuladas.
BRPI0510526A (pt) formulações lìquidas estabilizadas de interferon
CH700328B8 (de) O/W-Emulsion zur Pflege der Hand.
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
ATE357934T1 (de) Pharmazeutische zusammensetzung zur verhinderung der entwicklung und progression von mykotischen hautoberflächenerkrankungen
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AR034065A1 (es) Productos capilares que contienen aceites naturales con esteroles y acidos grasos insaturados y empleo de aceites naturales y de preparaciones
BRPI0415163A (pt) composição de xampu e usos de uma combinação de cera de abelha e silicone
ATE400262T1 (de) Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1531839

Country of ref document: EP